RecruitingNCT06885918
ALS Research Collaborative
ALS Translational Research Program
Sponsor
ALS Therapy Development Institute
Enrollment
2,000 participants
Start Date
Sep 12, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this natural history study is to learn more about the biological and clinical aspects of amyotrophic lateral sclerosis (ALS). This study's findings will help with drug discovery, biomarker discovery, and outcome measure validation. Adults living with ALS, other motor neuron diseases (MND), a known mutation related to ALS and healthy volunteers contribute prospective and retrospective data to this study remotely. The study is sponsored and conducted by the ALS Therapy Development Institute.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- years of age or older
- Can communicate in written English
- Has a diagnosis of ALS/MND or is a known carrier of an ALS associated mutation
Exclusion Criteria1
- Significant cognitive impairment that would prevent individual completion and understanding of the informed consent process.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06885918
Related Trials
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
NCT074781721 location
A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
NCT0710011912 locations
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis
NCT072212401 location
Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial
NCT0430287022 locations
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
NCT066499551 location